Method of inhibiting membrane-type matrix metalloproteinase
CA 2320260 A1 · Owner: Salo, Tuula · Inventors: Golub, Lorne M.; Teronen, Olli; Lee, Hsi-Ming
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is a method of inhibiting the activity of membrane-type matrix metalloproteinase (MT-MMP) in biological systems. Accordingly the invention , permits the treatment of medical conditions in mammals that are characterized by MT-MMP activity, and especially those conditions characterized by excessive MT-MMP activity. The method employs a tetracycline compound preferably a non-, antimicrobial tetracycline and more preferably 6-demethyl-6-deoxy-4de(dimethylamino)tetracycline (CMT-3) or 6-.alpha.-deoxy-5-hydroxy-4de(dimethylamino)tetracycline (CMT-8) to inhibit the MT-MMP activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 30, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.